IDXX Idexx Laboratories Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: IDXX

Price (delayed)

$543.5

Market cap

$42.87B

P/E Ratio

39.67

Dividend/share

N/A

EPS

$13.7

Enterprise value

$43.75B

?
Relative Growth: Rel. Growth: 91
Relative Strength: Rel. Strength: 28
Relative Valuation: Rel. Valuation: 28
Relative Profitability: Rel. Profitability: 96

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and ...

Highlights
The company's EPS rose by 25% YoY and by 4% QoQ
IDXX's price to earnings (P/E) is 24% lower than its 5-year quarterly average of 52.1 and 15% lower than its last 4 quarters average of 46.7
The company's equity rose by 7% YoY but it fell by 3.1% QoQ
The debt has grown by 14% from the previous quarter and by 4% YoY
The quick ratio has decreased by 3.1% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.idexx.com/
Peers: NEOG WOOF HSIC ABT

Key stats

What are the main financial stats of IDXX

IDXX stock price

How has the Idexx Laboratories stock price performed over time
Intraday
-0.41%
1 week
-5.15%
1 month
-2.84%
1 year
3.59%
YTD
-19.66%
QTD
-3.27%

Financial performance

How have Idexx Laboratories's revenue and profit performed over time
Revenue
$4.45B
Gross profit
$2.76B
Operating income
$1.41B
Net income
$1.1B
Gross margin
62.1%
Net margin
24.6%
IDXX's operating income is up by 23% YoY and by 3.4% from the previous quarter
The company's net income rose by 22% YoY and by 3.4% QoQ
The gross profit has increased by 15% YoY and by 3.7% QoQ
IDXX's revenue is up by 13% year-on-year and by 3.3% since the previous quarter

Price vs fundamentals

How does IDXX's price correlate with its fundamentals

Growth

What is Idexx Laboratories's growth rate over time

Valuation

What is Idexx Laboratories stock price valuation
IDXX P/E details
P/E
39.67
P/B
27.81
P/S
9.74
EV/EBIT
31.06
EV/EBITDA
28.09
EV/Sales
9.84
The company's EPS rose by 25% YoY and by 4% QoQ
IDXX's price to earnings (P/E) is 24% lower than its 5-year quarterly average of 52.1 and 15% lower than its last 4 quarters average of 46.7
The price to book (P/B) is 36% less than the 5-year quarterly average of 43.4 and 11% less than the last 4 quarters average of 31.2
The company's equity rose by 7% YoY but it fell by 3.1% QoQ
The P/S is 17% below the 5-year quarterly average of 11.8 and 14% below the last 4 quarters average of 11.4
IDXX's revenue is up by 13% year-on-year and by 3.3% since the previous quarter

Efficiency

How efficient is Idexx Laboratories business performance
Idexx Laboratories's return on equity has increased by 24% YoY
The return on assets rose by 21% year-on-year and by 2.2% since the previous quarter
Idexx Laboratories's return on invested capital has increased by 19% YoY and by 3.3% QoQ
The company's return on sales rose by 8% YoY

Dividends

What is IDXX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IDXX.

Financial health

How did Idexx Laboratories financials performed over time
The company's total assets is 85% higher than its total liabilities
IDXX's current ratio is down by 9% since the previous quarter and by 3.4% year-on-year
The company's total assets rose by 5% YoY
The debt is 31% less than the equity
IDXX's debt to equity is up by 17% QoQ but it is down by 4.2% YoY
The debt has grown by 14% from the previous quarter and by 4% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.